acyclovir
Generic: acyclovir
Labeler: major pharmaceuticalsDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
major pharmaceuticals
Dosage Form
CAPSULE
Routes
Active Ingredients
acyclovir 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0904-5789
Product ID
0904-5789_3b18620a-e798-4ce1-955c-72a1d0f35db8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075677
Marketing Start
2006-03-20
Marketing End
2026-08-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
09045789
Hyphenated Format
0904-5789
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA075677 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 100 BLISTER PACK in 1 CARTON (0904-5789-61) / 1 CAPSULE in 1 BLISTER PACK
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3b18620a-e798-4ce1-955c-72a1d0f35db8", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["864d96b9-e2de-45a8-850b-6f7b72ceefe1"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-5789-61) / 1 CAPSULE in 1 BLISTER PACK", "package_ndc": "0904-5789-61", "marketing_end_date": "20260831", "marketing_start_date": "20060320"}], "brand_name": "ACYCLOVIR", "product_id": "0904-5789_3b18620a-e798-4ce1-955c-72a1d0f35db8", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "0904-5789", "generic_name": "ACYCLOVIR", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACYCLOVIR", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA075677", "marketing_category": "ANDA", "marketing_end_date": "20260831", "marketing_start_date": "20060320"}